Gene content | ||||
---|---|---|---|---|
VCL ( by HUGO) | ||||
Vinculin | ||||
Tumor suppressor gene | ||||
vinculin metavinculin MV CMD1W CMH15 HEL114 MVCL Epididymis Luminal Protein 114 Metavinculin | ||||
NCBI: 10q22.2 Ensembl: 10q22.2 | ||||
|
Protein Domain/Family | ||||
---|---|---|---|---|
Source | ID | Domain | Name | Type |
InterPro | IPR000633 | Vinculin_CS | Vinculin | Family |
IPR006077 | Vinculin/catenin | Vinculin/alpha-catenin | Family |
Gene Ontology | ||||
---|---|---|---|---|
Type | Term | Evidence | Source | Pub |
Biological Process | apical junction assembly | IMP | GOA | 9700171 |
cell adhesion | TAS | GOA | 15501673 | |
cellular component movement | TAS | GOA | 16130169 | |
negative regulation of cell migration | TAS | GOA | 15494027 | |
Cellular Component | cell-substrate junction | NAS | GOA | 2116004 |
costamere | IDA | GOA | 9415431 | |
cytoskeleton | TAS | GOA | 16130169 | |
extracellular vesicular exosome | IDA | GOA | 19056867 | |
protein complex | IDA | GOA | 9700171 | |
Molecular Function | actin binding | IDA | GOA | 16803572 |
alpha-catenin binding | IPI | GOA | 9700171 | |
dystroglycan binding | IPI | GOA | 18341635 | |
NOT actin binding | IDA | GOA | 7816144 | |
protein binding | IPI | GOA | 10320934 |
Disorder & Mutation | ||||
---|---|---|---|---|
Source | Disease | |||
SWISS-PROT | Cardiomyopathy, dilated 1W (CMD1W) [MIM:611407]: A disorder characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. Patients are at risk of premature death. Note=The disease is caused by mutations affecting the gene represented in this entry | |||
SWISS-PROT | Cardiomyopathy, familial hypertrophic 15 (CMH15) [MIM:613255]: A hereditary heart disorder characterized by ventricular hypertrophy, which is usually asymmetric and often involves the interventricular septum. The symptoms include dyspnea, syncope, collapse, palpitations, and chest pain. They can be readily provoked by exercise. The disorder has inter- and intrafamilial variability ranging from benign to malignant forms with high risk of cardiac failure and sudden cardiac death. Note=The disease is caused by mutations affecting the gene represented in this entry |
VCL cross reference | ||||||||
---|---|---|---|---|---|---|---|---|
|